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Objectives: Although ceil culture techniques and animal models of intimal hyperplasia have increased our current 
understanding ofthe aetiology of vein graft stenosis, the results of such studies have been difficult to relate to the human 
situation. 
Design" The present study was designed to validate an organ culture of human saphenous vein by comparing tlie changes 
occurring in cultured vein with those seen in pathological vein graft stenoses and to identify a suitable marker of cell 
proliferation. 
Materials and methods: Saphenous vein segments were cultured for 14 days, fixed in formalin and processed for 
immunohistochemistry. Freshly excised stenoses were fixed and processed similarly. A number of markers of cell 
proliferation were evaluated in the culture system in order to identify the one best suited to this particular model. 
Results. Marked similarities were observed in the cellular and extracellular matrix composition, and electron microscopy 
revealed that both the neointima of the cultured vein and the pathological lesion contained an abundance of smooth muscle 
cells of a secretory phenotype. Bromodeoxyuridine proved to be the most reliable proliferation marker and revealed that early 
proliferation in the superficial ayers of the vein intima gave rise to the formation of neointima. Both proliferation and 
neointimal thickness were maximal by day 14 in culture. Proliferation declined rapidly thereafter, and the neointima was 
maintained. 
Conclusions: The changes occurring in cultured vein and graft stenoses bore many similarities, thereby justifying the use 
of organ culture as a valuable experimental tool. 
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Introduction 
The widespread use of animal models of intimal 
hyperplasia provides a valuable experimental tool, 
and although such studies have undoubtedly 
increased our understanding of the aetiology of this 
condition, the results, particularly in small animals, 
may not be applicable to the human situation. Like- 
wise, isolated cell culture techniques have been useful 
in probing the underlying cellular mechanisms of 
intimal hyperplasia, but again, the results of such in 
vitro studies should be interpreted with caution. 
In 1956 Trowell studied the behaviour of a variety of 
organs in culture, ~ and concluded that it was possible 
to maintain the viability of tissues that were naturally 
flat or thin. In 1990 Soyombo et al. first described organ 
culture of human saphenous vein as an in vitro model 
of vein graft intimal hyperplasia. 2 After culturing 
segments of vein for 14 days in serum-supplemented 
medium they reported the appearance of an intimally- 
directed smooth muscle cell proliferation, resulting in 
the formation of a cellular sub-endothelial layer or 
"neointima'. The advantage over isolated cell culture 
techniques that organ culture offers is that it is 
possible to maintain the integrity and architecture of 
the vein wall and thereby study the interactions 
between the endothelium and smooth muscle cells. 
The aim of this study was to further define the 
kinetics of the culture model and to compare this in 
vitro model with clinical in vivo lesions. Smooth 
muscle cell proliferation is an early event in the 
development of such lesions, but the kinetics of this 
process in human tissue have not previously been 
described. Cellular proliferation can be assessed by 
the use of a number of techniques including [3H] 
thymidine labelling, Ki 67 immunostaining, local- 
isation of Proliferating Cell Nuclear Antigen (PCNA) 
and labelling with the thymidine-analogue 5-Bromo- 
eoxyuridine (BrdU). All of these methods have 
advantages and also problems associated with them, 6
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therefore we conducted a preliminary study in order 
to identify the one best suited to assessing prolifera- 
tion in this model. 
Materials and Methods 
Vein collection procedure 
Saphenous vein samples were obtained from patients 
undergoing either coronary artery or femoropopliteal 
bypass grafting. The veins were dissected with mini- 
mal handling from the calf and samples taken before 
distension or valve stripping procedures. They were 
transported to the laboratory at 4°C in a calcium - free 
Krebs solution (millimolar composition; NaC1 118, KC1 
4.7, MgSO4.7H20 1.2, KI-I2PO 4 1.2, NaHCO 3 25 and 
glucose 11.1) and prepared for organ culture. Only 
veins that were macroscopically normal were included 
in the study. 
Culture procedure 
Upon arrival in the laboratory all veins were assessed 
for endothelial cell coverage by trypan blue exclusion. 
Representative s gments were incubated for 1-2 min 
at room temperature in Dulbecco's phosphate - buff- 
ered saline containing 0.01% trypan blue (Flow Labo- 
ratories) to visually assess endothelial integrity. 3 Veins 
with less than 70% endothelial coverage were 
excluded from the study. Organ cultures were set up 
using a technique previously described by Soyombo et 
al. 2 Briefly, excess fat and adventitial tissue was 
dissected from the vessels, which were then opened 
up longitudinall~ and cut into 0.5 cm lengths. They 
were pinned out, lumenal surface uppermost, onto a 
500/~m mesh resting on a layer of preformed Sylgard 
resin (Dow Corning, Seneffe, Belgium) in the bottom 
of a glass petri dish. Cultures were maintained in 
RPMI 1640 medium (Northumbria Biologicals Ltd, 
U.K.), supplemented with 30% foetal calf serum 
(Seralab, U.K.), for 14 days at 37°C in static conditions 
in a humidified atmosphere of 5% CO2 in air in an 
incubation chamber. The culture medium was 
replaced every 2-3 days. 
At the end of the culture period veins were fixed 
overnight in 10% formal saline followed by processing 
and paraffin embedding, from which serial sections of 
4/zm were cut for the application of immunohis- 
tochemical stains. Six representative portions of cul- 
tured vein were also fixed in 4% buffered gluter- 
aldehyde and processed for transmission electron 
microscopy (TEM). They were rinsed in cacodylate 
buffer and post-fixed in 1% Osmium Tetroxide for I h. 
This was followed by dehydration through graded 
ethanols and embedding in Emix resin. Thin (90 nm) 
sections were cut and mounted onto 200/1m copper 
grids and double stained with uranyl acetate and lead 
citrate. The grids were screened and photographed 
using a Jeol 100CX transmission electron microscope 
at 80 KV. 
Immunohistochemical techniques 
Sections of cultured veins and vein graft stenoses were 
exposed to the following stains: 
(i) Haematoxylin and Eosin (H&E). 
(ii) A combination of monoconal anti - smooth 
muscle ~ - actin and Millers elastin stain4(SMA/ 
Millers). This is a novel combination using an indirect 
immunoperoxidase method to localise smooth muscle 
actin, which was achieved by incubation with mono- 
clonal anti-~ -smooth muscle actin (DAKO M851, 
High Wycombe, Bucks). Colour development was 
effected with diaminobenzidine (DAKO) and sections 
were washed and counterstained with acid haematox- 
ylin; followed by the application of a Millers elastin 
stain to localise the internal elastic lamina (IEL). 
(iii) QB END 10 monoclonal antibody (Novocastra 
507). This antibody was used to identify the endothe- 
lium. 5 The antigen is associated with the basolumenal 
surfaces of endothelium, with predominant staining 
on the inter - endothelial cell membranes. 
(iv) Alcian blue/PAS stain (pH 2.5) for glycosamino- 
glycans. This combined stain was used to identify 
neutral and acid mucin components of the extrac- 
ellular matrix (ECM). Alcian blue was applied initially, 
and briefly counterstained with fast red to identify 
acid mucins; following this PAS was applied, and 
counterstained with Mayers haematoxylin to identify 
neutral mucins. Finall)~ all histological sections were 
dehydrated, cleared in xylene and mounted. 
Measurement of neointimal thickness 
Measurements of neointimal thickness were made 
using a computerised image analysis ystem (Kontron 
Videoplan, Munich, Germany). The neointima was 
defined as the new cellular layer developing in culture 
beneath the endothelium on the lumenal side of the 
internal elastic lamina. A total of 30 measurements 
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were made on each vein evenly distributed across 
three consecutive sections, by two independent 
observers. The mean result of both observers was 
taken as the final measurement. 
Preliminary proliferation studies 
Assessment of the following markers was performed 
at the end of the 14 day culture period, and compar- 
isons made between them: 
(i) Tritiated thymidine labelling. This is considered 
to be the "gold standard" for cell kinetic studies. This 
method requires viable cells to take up tritiated 
thymidine and for this to be incorporated into DNA. 
Cultured veins (n = 10) were incubated with 2~Ci/ml 
[3H] thymidine (Amersham, U.K.) for the final 24 h of 
the culture period. They were then homogenised, 
pelleted and the DNA was extracted by heating to 
90°C with 0.5N perchloric acid for 20 min. An aliquot 
was taken for scintillation counting in order to 
determine the amount of [3H] incorporated into the 
DNA, and the remainder assayed for DNA by the 
method of Burton et aI. 7 From these determinations it 
was then possible to calculate a thymidine index 
(cpm/~g DNA). 
(ii) Ki 67. This antibody recognises a poorly charac- 
terised nuclear antigen associated with the cell cycle, 
being expressed in all phases except Go. Ki 67 is only 
effective on frozen sections, hence portions of the 
cultured veins (n = 10) were snap frozen at the end of 
the 14 day culture period prior to sectioning and 
immunostaining. 
(iii) Proliferating cell nuclear antigen (PCNA) is a 
cellular protein involved in DNA synthesis which can 
be detected immunologically. PCNA expression was 
examined using paraffin-embedded tissue (n = 10) and 
localised using PC10 monoclonal antibody (DAKO). 
(iv) 5-Bromodeoxyuridine (BrdU). This is a method 
of assessing incorporation of a thymidine analogue 
into DNA and localising proliferating cells using a 
monoclonal antibody. For this part of the study, 10 
veins were studied. Each vein was cut into three equal 
portions, which were then cultured under the stan- 
dard conditions already described. Cultured veins 
were incubated with BrdU (Amersham, U.K.) at a 
1:1000 dilution in the following manner: 
(i) 14 day culture, continuous labelling. 
(ii) 14 day culture, no labelling. 
(iii) 14 day culture, labelled between days 10 and 
14. 
Following all of the above procedures, vein portions 
were immediately formalin - fixed, processed, paraffin 
- embedded and 4~m sections were stained using anti- 
BrdU antibody (DAKO M744). To investigate he effect 
of continuous exposure to BrdU, the neointimal 
thickness of the unlabelled portion of each vein was 
compared with that of the continuously labelled 
portion for the 14 day culture period. The optimum 
technique for measuring proliferation in this model 
was found to be Bromodeoxyuridine labelling (see 
results section below) and therefore this method was 
used preferentially for the kinetics study. 
Proliferation kinetics 
For this part of the study a further 10 veins were 
studied. Each vein was cut into six equal portions, 
cultured under standard conditions, and labelled 
sequentially with BrdU in the following manner: 
(i) 4 day culture, labelled between days 0 and 4. 
(ii) 7 day culture, labelled between days 4 and 7. 
(iii) 10 day culture, labelled between days 7 and 
10. 
(iv) 14 day culture, labelled between days 10 and 
14. 
(v) 18 day culture, labelled between days 14 and 
18. 
(vi) 21 day culture, labelled between days 18 and 
21. 
Following fixation, identification and localisation of 
proliferating cells was carried out as described above. 
By counting the total number of neointimal-labelled 
and unlabelled cells a proliferation index was calcu- 
lated by expressing BrdU-labelled cells as a percentage 
of the total number of neointimal cells along the 
section length. Counts were made by two independent 
observers on each high power field across the entire 
transverse section of the intima of three consecutive 
sections and the mean taken as the final result. 
Comparison with pathological vein 
In order to compare the changes een in cultured 
saphenous vein in vitro with those observed in vein 
graft stenoses in vivo, five pathological specimens of 
excised stenoses were fixed as described above and 
processed for both immunohistochemistry andTEM. 
All five patients were male with a median age of 67 
years (range 49-73). All the grafts were below-knee 
femoropopliteal, three in situ and two reversed. The 
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median time to development of the stenosis was 14 This method was therefore chosen as being ideally 
months (range 7-60). suited to the current study. 
Statistics Kinetics 
All values are expressed as medians and range. 
Differences between the groups were analysed using a 
Wilcoxon paired rank test with 95% confidence 
intervals. 
Results 
Preliminary proliferation studies 
(i) The measurement of thymidine indices gave very 
variable results, ranging from 200-2000 cpm///zg 
DNA. Moreover, this method only gave a measure of 
total uptake in the whole vein segments, and therefore 
emphasised a need to precisely localise the cells 
undergoing proliferation. Although autoradiography 
was considered, it was felt that immunohistochemical 
techniques would yield more information. The use of 
such a marker delineated the internal elastic lamina, 
and hence allowed precise localisation of proliferating 
cells in the different layers of the vein wall. 
(ii) Ki 67, apart from an occasional positively stained 
cell the majority were negative. The use of this 
antibody was restricted to one time point, i.e. at the 
end of the 14 day culture period. Additionally, loss of 
morphology through the use of frozen sections 
emphasized a disadvantage of this method, as main- 
tenance of the vein wall integrity represented an 
important part of this study. 
(iii) PCNA. More staining was seen with this 
proliferation marker, however the extent was variable 
and the pattern of staining was difficult to interpret. 
Both nuclear and cytoplasmic staining was observed, 
with enhanced staining at the cut edges of the vein. 
It is known that there are inherent problems with 
PCNA. 8 Firstly, owing to its long half life it will 
identify cells which are no longer proliferating. There 
is also a suggestion that PCNA is expressed in 
response to other stimuli such as trauma, which could 
explain the enhanced staining at the cut edges of the 
vessel. For these reasons it was concluded that PCNA 
was not a useful marker in this study. 
(iv) BrdU. The technique of interval pulsing pro- 
vided a wealth of information on both the location and 
number of proliferating cells, and allowed the calcula- 
tion of a proliferation index for any one time interval. 
The results of the measurement of proliferation indices 
and neointimal thickness are summarised in Fig. 1. 
An early burst of proliferation was observed in the 
superficial layers of the vein intima between days 4 
and 7 (Fig. 2a), reaching apeak value between days 10 
and 14 (p < 0.003, days 4-7 vs. 10-14). Neointimal 
development initially lagged behind these prolifer- 
ative events, with a marked increase in neointimal 
thickness occurring between days 7 and 10, but this 
finally also reached a maximum by day 14, with many 
cells throughout he neointima staining positively 
with BrdU (Fig. 2b). After 21 days the proliferation 
index had dropped dramatically and the majority of 
proliferating cells were confined to the lumenal 
surface of the neointima, with negligible proliferation 
in the deeper layers (Fig. 2c). However the neointima 
was maintained with no further significant increase in 
thickness throughout the period of the study. 
Bromodeoxyuridine toxicity 
By the use of continuous labelling of the 14 day 
50- 
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T o Neointlmal thickness (itm) 
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0-4 4-7 7-10 10-14 14-18 18-21 
Pulsing period (days) 
Fig. 1. Line graph to show the relationship between proliferation 
index and neointimal thickness with time,-in cultured vein. 
Proliferation initially preceded neointimal thickening, but in each, 
the response was maximal by 14 days after which proliferation 
declined rapidly and neointimal thickness was maintained. 
(Bars = 95% confidence intervals). 
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(a) 
(b) 
(c) 
Fig. 2. Bromodeoxyuridine (BrdU) labelling of proliferating smooth muscle c lls in cultured vein showing: (a) A burst of proliferation in the 
superficial layers of the vein intima between days 4 and 7. (b) An abundance of positively stained cells throughout he neointima (arrowed) 
between days 10 and 14. (c) By 21 days, proliferation had diminished, and was confined almost entirely to the superficial layers of the 
neointima (arrowed). (All Magnification × 320). Reproduced here at 50%. 
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Fig. 3. Scatter plot to show the effect of pulse-labelling and 
continuous BrdU labelling on neointimal thickness of cultured 
veins. Continuously labelled veins developed significantly ess 
neointima than pulse-labelled or unlabelled veins (p < 0.0002). There 
was no significant difference b tween the neointimal thicknesses of 
the pulse-labelled and unlabelled groups (p = 0.34). 
cultured veins, it was envisaged that the total number 
of cells that had undergone proliferation could be 
assessed. However, when the neointimal thicknesses 
of the two groups (continuously labelled vs. unlab- 
elled) were compared, a significant reduction in 
neointimal thickness was observed in the labelled 
group (Median difference = 11.25, 95% confidence 
interval = 7.5, 19.5, p = 0.0002, Fig. 3). This observa- 
tion clearly demonstrated a toxic effect of continuous 
labelling, which did not occur when the veins were 
pulse labelled, as no significant difference in neointi- 
mal thickness was observed when comparing 14 day 
unlabelled veins with 14 day veins exposed to BrdU 
for only the final 72 h. (Median difference = 2.0, 95% 
confidence interval = -6.0, 2.5, p = 0.34). 
Similarity between cultured and pathological vein 
In all five excised stenoses the pattern of staining seen 
with each of the markers was similar. The H&E stain 
clearly demonstrated the presence of a highly cellular 
intima, and furthermore, the combined stain con- 
firmed that all of these cells stained positively for 
smooth muscle actin (Fig. 4a). The majority of these 
were identified on TEM as smooth muscle cells of a 
secretory phenotype (Fig. 5a). The application of the 
alcian b lue/PAS stain showed that these cells were 
surrounded by an abundance of mucopolysaccharides 
in the extracellular matrix (Fig. 6a). 
In the cultured veins a new intima had developed, 
clearly distinguishable from the original intima, but 
staining positively for SMA (Fig. 4b), and identifiable 
on TEM as having a predominantly secretory pheno- 
type (Fig. 5b). Furthermore, the alcian blue/PAS stain 
demonstrated an ECM composition analogous to that 
of the pathological stenoses (Fig. 6b). The presence of 
an intact endothelium on the lumenal surface was 
demonstrated by QB END 10, but other structures in 
the neointima were occasionally stained with this 
antibody. These have previously been observed and 
described as "heavily stained profiles suggesting 
capillary lumeni'.2 Although new vessel formation is 
not a common feature in the intima of vein grafts they 
have been described by Sottiurai as "an unusual 
observation "9 in an ultrastructural study of throm- 
bosed human grafts. 
Owing to the fact that most vein graft stenoses are 
successfully treated by balloon angioplasty and not 
surgical excision, the numbers in this study are small. 
However they fell into two groups. Two stenoses 
showed only extensive intimal smooth muscle cell 
proliferation, and the other three, smooth muscle cells 
with variable amounts of elastic fibres. Our model is 
more representative of the former, as elastin staining 
in the neointimal layer was rarely observed. 
Discussion 
Choice of proliferation marker 
In the current study we assessed the relative values of 
a number of proliferation markers in the organ culture 
model. Since cellular proliferation is a fundamental 
biological process, the facility to quantify the extent o 
which it occurs in both normal and pathological 
material provides a valuable research tool. The mark- 
ers described in this study measure slightly different 
variables, and although they are comparable they are 
not identical, and all these methods have limitations. 6 
Having assessed each of them, it was concluded that 
bromodeoxyuridine was the best available marker. A 
particular advantage of this method was that it 
allowed not only the quantification of cellular pro- 
liferation, but also its localisation. 
Bromodeoxyuridine toxicity 
Both [3H]thymidine and BrdU are capable of produc- 
ing toxic effects and can possibly influence cell 
proliferation in experimental studies. 0 In a study by 
Hanke et al. 11 the cytotoxic effects of BrdU were 
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(a) 
(b) 
Fig. 4. Smooth muscle actin/Millers elastin stain on (a) vein graft stenosis (magnification x 32), and (b) cultured vein (magnification × 320), 
showing an abundance of positively stained cells in the stenotic lesion and in the neointima (arrowed) of the cultured vein. Reproduced 
here at 60%. 
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minimised by  l imiting in vivo labell ing in the rabbit to The present s tudy demonstrated that cont inuous 
a time interval of 18 h pr ior to excision of the vessels, labelling of the vein cultures with BrdU produced 
(a) 
(b) 
Fig. 5. Transmission electron micrograph (TEM) of (a) typical intimal cell of vein graft stenosis ( × 10000), and (b) neointimal cell of cultured 
vein ( × 16000), showing that highly secretory smooth muscle cells with large amounts of rough endoplasmic reticulum were common to 
both. Reproduced here at 80%. 
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(a) 
(b) 
Fig. 6. Alcian blue/PAS stain for mucopolysaccharides in the extracellular matrix of (a) vein graft steuosis (magnification x 80) and (b) 
neointima of cultured vein (magnification × 320), showing similarity of the extracellular matrix composition i each. Reproduced here at 
60%. 
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toxic effects, however this was abolished by the 
introduction of sequential labelling over a period of 
72 h. 
Proliferation kinetics of the model 
The results of the present study demonstrate a burst of 
cellular proliferation between the fourth and seventh 
days in culture. At this time there were only few 
neointimal cells, but high levels of labelling with 
BrdU. This observation is consistent with the observa- 
tions of Dilley et al. 12 who showed that in a rat vein 
graft model 5 days after implantation there were few 
neointimal cells, but high [3H]thymidine labelling 
levels in the graft intima. In these grafts it was shown 
that high labelling levels were maintained throughout 
the most active neointimal development (5-14 days 
after grafting), and declined steadily thereafter up to 
28 days by which time they had returned to baseline 
levels. These observations are mirrored in our model 
where the proliferation index reached a maximum of 
42% at day 14, and declined rapidly thereafter to a 
level of 14% by the 21st day. It was not feasible to 
continue the present study beyond 3 weeks, owing to 
progressive loss of tissue viability after this time, 
smooth muscle cell necrosis and loss of contractile 
responses to vasoactive agents (unpublished 
observations). 
Clowes and Clowes reported similar findings using 
a balloon-injured rat carotid artery as their model. 13 
Following balloon inju13~ at 7, 14 and 28 days the 
intima became progressively thicker as cells accumu- 
lated, and intimal thickening was maximal at 28 days. 
Smooth muscle cell proliferation, as documented by 
thymidine-labelling indices was greatest at 7 days in 
the intima and returned towards baseline by 4 
weeks. 
Hanke et aI. 11 used angioplasty of the atheromatous 
rabbit carotid artery as a model for investigating and 
quantifying intimal proliferative responses using 
BrdU labelling. Smooth muscle cell DNA synthesis 
preceded the onset of intimal thickening, with a peak 
value of DNA synthesis occurring during the first 7 
days after injury. The number of SMC's undergoing 
DNA synthesis decreased between days 7 and 14 after 
angioplast35 until cell division approached baseline 
levels between days 21 and 28 after interventional 
treatment. 
Although the results of these animal studies are 
similar to those of the present study, it must be noted 
that each of these investigations were performed on 
balloon-injured arteries. Arterial intimal hyperplasia 
develops when cell proliferation and migration are 
significantly increased after trauma and accompany- 
ing endothelial denudation. 13"14 However the surgical 
trauma which occurs during harvesting and insertion 
of a vein graft is also a likely stimulus for increasing 
cell proliferation. Experimental models of vein graft- 
ing have provided us with information on the histoge- 
nesis of neointimal hyperplasia, but evidence on the 
role of cellular proliferation and its quantification is
scant, as shown for example by mitotic figures 15 or 
[3H]thymidine uptake. 16 It is therefore an important 
observation that the kinetics of the present in vitro 
study parallel those observed in vivo by Dilley. 12 
The control mechanisms ofSMC proliferation i  the 
vein wall are as yet unknown, but cells in the vessel 
wall are capable of producing growth factors and 
growth inhibitors. 17-2° In order to develop possible 
means of controlling the development of intimal 
hyperplasia nvein grafts, the modulation of autocrine 
or paracrine control on SMC growth in response to 
physical stimuli has been suggestedY "22 With regard 
to potential pharmacological treatment, from the 
results of this study and those mentioned above, it 
appears to be important that any form of anti- 
proliferative therapy should be commenced at an 
early stage, either at the time of surgery or imme- 
diately following vein grafting. 
Having demonstrated in this study that organ 
culture of the human saphenous vein closely mimics 
the intimal hyperplasia that underlies vein graft 
stenoses, then this model may continue to provide a 
useful experimental system for further investigation 
into the aetiology and amelioration of human vein 
graft stenoses. 
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